Carregant...
All-cause mortality risk with direct oral anticoagulants and warfarin in the primary treatment of venous thromboembolism
Oral anticoagulants used for the primary treatment of venous thromboembolism (VTE) include warfarin and the more recently introduced direct oral anticoagulants (DOACs), including rivaroxaban, apixaban, dabigatran, and edoxaban. Information on the comparative safety of these medications in routine cl...
Guardat en:
| Publicat a: | Thromb Haemost |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6172009/ https://ncbi.nlm.nih.gov/pubmed/30103250 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0038-1668521 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|